Skip to main content

Table 2 Evaluation of antimicrobial agents used, and microorganisms identified in ASB (N = 104)

From: Evaluation of asymptomatic bacteruria management before and after antimicrobial stewardship program implementation: retrospective study

Number of antimicrobial agents, n

151

Duration, mean

12 d

Route of administration, n (%)

 IVa

89 (59)

 POb

46 (30.4)

 IV to PO

16 (10.6)

Type of antimicrobial agents, n (%)

Quinolones

29 (19.2)

β-lactam

73 (48.3)

  Penicillin

11 (7.28)

  Cephalosporin

 

   2nd generation

33 (21.85)

   3rd generation

29 (19.21)

Carbapenem

44 (29.14)

Vancomycin

1 (0.66)

Others

4 (2.65)

Microorganisms identified (N = 116)

Gram-positive, n (%)

11 (9.40)

  Enterococcus

7 (6.03)

  Coagulase negative staph

2 (1.72)

  Streptococcus group B

2 (1.72)

Gram-negative, n (%)c

105 (90.2)

  E. coli

54 (46.55)

  K. pneumonie

23 (19.83)

  Pseudomonas

13 (11.21)

  Citrobacter

3 (2.59)

  others

12 (10.35)

  1. aIV = intravenous; bPO = orally
  2. c Multidrug Resistance was 45 (38.7%) isolates in the urine